Understanding Viruses CHAPTER 38. Antiviral Agents. Understanding Viruses (cont'd) Viral Infections (cont'd) Viral Infections.

Similar documents
Anti-viral drugs. Certain viruses multiply in the cytoplasm but others do in the nucleus Most multiplication take place before diagnosis is made

Anti-viral drugs. Certain viruses multiply in the cytoplasm but others do in the nucleus Most multiplication take place before diagnosis is made

Antiviral Drugs Lecture 5

Antiviral Chemotherapy

Antiviral Agents DEPARTEMEN FARMAKOLOGI & TERAPEUTIK FK USU. 06 August

number Done by Corrected by Doctor Ashraf

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV)

Viral genetics VIRAL GENETICS

THE HIV LIFE CYCLE. Understanding How Antiretroviral Medications Work

0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920

HIV medications HIV medication and schedule plan

Chapter 49. Antiviral Agents

HIV - Life cycle. HIV Life Cyle

HIV Drugs and the HIV Lifecycle

Antiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

- They come in all sizes. -- General Structure is similar.

The head of a pin can hold five hundred million rhinoviruses (cause of the

Antiviral Drugs. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Immunodeficiencies HIV/AIDS

Antiviral Agents, chapter 43

Steps in viral replication (I)

Structure of viruses

Year 2002 Paper two: Questions supplied by Jo 1

Treatment of respiratory virus infection Influenza A & B Respiratory Syncytial Virus (RSV) modified by Diala Abul Haija

*viruses have no cell wall and made up of nucleic acid components.

Quick Reference Guide to Antiretrovirals. Guide to Antiretroviral Agents

Antiviral Chemotherapy

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 03/07/18 SECTION: DRUGS LAST REVIEW DATE: 02/19/19 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Herpes Simplex Viruses. HSV-1 HSV-2 Herpesvirus hominis Infection mucocutaneous surfaces, CNS

HIV and AIDS. Shan Nanji

MedChem 401~ Retroviridae. Retroviridae

Antiviral Agents I. Tutorial 6

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

HSV DNA replication. Herpesvirus Latency. Latency and Chemotherapy. Human Herpesviruses - subtypes. Acyclovir (acycloguanosine) {Zovirax}

B. Incorrect! Peginterferon α-2a is used for the treatment of chronic hepatitis B and may be preferable to interferon- α.

Nobel /03/28. HIV virus and infected CD4+ T cells

Medscape's Antiretroviral Pocket Guide for the Treatment of HIV Infection

Antiviral Therapies in Children: Has Their Time Arrived?

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

The Annotated Bibliography of the UCSF HIV Solid Organ Transplantation Project. ARV Dosing in End Stage Renal Disease

WOMENS INTERAGENCY HIV STUDY ANTIRETROVIRAL DOSAGE FORM SECTION A. GENERAL INFORMATION

Continuing Education for Pharmacy Technicians


Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

PROGRESSIVE MULTI-FOCAL LEUKOENCEPHALOPATHY

Nothing to disclose.

HIV epidemiology since HIV in the United States. HIV Transmission

Zalcitabine 2-3 -dideoxycytidine, ddc TUD DaMocles SoSe 15

Terapia antirretroviral inicial y de rescate: Utilidad actual y futura de nuevos medicamentos

Diagnosis of Viral Infections. Antiviral Agents. Herpes Zoster. Challenges to the Development of Effective Antiviral Agents

Prokaryotic Biology. VIRAL STDs, HIV-1 AND AIDS

MID 40. Diagnosis of Viral Infections. Antiviral Therapy. Herpes Zoster. Challenges to the Development of Effective Antiviral Agents

Northwest AIDS Education and Training Center Educating health care professionals to provide quality HIV care

Human Immunodeficiency Virus (HIV)

HIV THERAPY STRATEGIES FOR THIRD LINE. issues to consider when faced with few drug options

Non HIV Anti Virals Prof. Mary Klotman

HIV Update Objectives. Epidemiology. Epidemiology, Transmission and Natural History. Transmission Risk by Exposure. Transmission 9/29/2014

Drug Treatment Program Update

Michał Karbownik Department of Pharmacology Medical University of Łódź

WOMEN'S INTERAGENCY HIV STUDY METABOLIC STUDY: MS01 SPECIMEN COLLECTION FORM

Chapter 22. Autoimmune and Immunodeficiency Diseases

Antiviral Agents. Scott M. Hammer, M.D. Challenges to the Development of Effective Antiviral Agents

number Done by Corrected by Doctor

Virology Introduction. Definitions. Introduction. Structure of virus. Virus transmission. Classification of virus. DNA Virus. RNA Virus. Treatment.

Medical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses

gram neg.(semisynthetic) Bacteria Drugs that inhibit cell wall synthesis Drug Action Organisms Comments Spectrum of Action Mycobacterium

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

0% 0% 0% Parasite. 2. RNA-virus. RNA-virus

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

ACQUIRED IMMUNODEFICIENCY SYNDROME AND ITS OCULAR COMPLICATIONS

C h a p t e r 5 5 HIV Therapy Where are We Now?

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

October 26-28: Training Day 1

Human Herpes Viruses (HHV) Mazin Barry, MD, FRCPC, FACP, DTM&H Assistant Professor and Consultant Infectious Diseases KSU

Section H: Treatments

Genotyping and Drug Resistance in Clinical Practice. Case Studies

medical monitoring: clinical monitoring and laboratory tests

Chapters 21-26: Selected Viral Pathogens

HIV/AIDS Prevention Education As A Means of Prevention

Chapter III ANTIVIRAL AND ANTIFUNGAL DRUGS

HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND AIDS

Infant and Pediatric Influenza. Mike Czervinske RRT-NPS University of Kansas Medical Center

Immunodeficiency. (2 of 2)

POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV

NON-OCCUPATIONAL POST EXPOSURE PREVENTION. when you think you were exposed to hiv within the past three days

HIV THERAPY STRATEGIES FOR FIRST LINE. issues to think about when going on therapy for the first time

Principles of Antiretroviral Therapy

Repetitorium of selected human viruses HIV

HIV & AIDS: Overview

Overview of HIV. LTC Paige Waterman

Overview of HIV WRAIR- GEIS 'Operational Clinical Infectious Disease' Course

Antivirals. Lecture 20 Biology 3310/4310 Virology Spring 2017

SECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.

Medication Guide. VIDEX EC (VY-dex Ee-see) (didanosine, also known as ddi) Delayed-Release Capsules Enteric-Coated Beadlets

ADAP Monitoring Provider Prescribing Patterns. Amanda Bowes, NASTAD Christine Rivera and Dr. Charles Gonzalez, NYS AIDS Institute

Multiple Choice Questions - Paper 1

MONTGOMERY COUNTY COMMUNITY COLLEGE CHAPTER 13: VIRUSES. 1. Obligate intracellular parasites that multiply in living host cells

AIDS 101: From Abstinence to Zidovudine

Transcription:

Understanding Viruses CHAPTER 38 Antiviral Agents Viral replication A virus cannot replicate on its own It must attach to and enter a host cell It then uses the host cell s energy to synthesize protein, DNA, and RNA Mosby items and derived items 2005, 2002 by Mosby, Inc. 1 Mosby items and derived items 2005, 2002 by Mosby, Inc. 2 Understanding Viruses (cont'd) Viruses are difficult to kill because they live inside our cells Any drug that kills a virus may also kill our cells Figure 38-1 Virus replication. Some viruses integrate into host chromosome with development of latency. (Modified from Brody TM, Larner J, Minneman KP: Human pharmacology: molecular to clinical, ed 3, St. Louis, 1998, Mosby.) Mosby items and derived items 2005, 2002 by Mosby, Inc. 3 Mosby items and derived items 2005, 2002 by Mosby, Inc. 4 Viral Infections Competent immune system: Best response to viral infections A well-functioning immune system will eliminate or effectively destroy virus replication Viral Infections (cont'd) Immunocompromised patients have frequent viral infections Cancer patients, especially leukemia or lymphoma Transplant patients, due to pharmacologic therapy AIDS patients, disease attacks immune system Mosby items and derived items 2005, 2002 by Mosby, Inc. 5 Mosby items and derived items 2005, 2002 by Mosby, Inc. 6

Antivirals Viruses killed by current antiviral therapy Cytomegalovirus (CMV) Hepatitis viruses Herpes viruses Human immunodeficiency virus () Influenza viruses (the flu ) Respiratory syncytial virus (RSV) Mosby items and derived items 2005, 2002 by Mosby, Inc. 7 Antivirals (cont'd) Key characteristics of antiviral drugs Able to enter the cells infected with virus Interfere with viral nucleic acid synthesis and/or regulation Some agents interfere with ability of virus to bind to cells Some agents stimulate the body s immune system Mosby items and derived items 2005, 2002 by Mosby, Inc. 8 Antiviral Medications Antiviral agents Used to treat infections caused by viruses other than Antiretroviral agents Used to treat infections caused by, the virus that causes AIDS Antiviral Agents: Nonretroviral Mechanism of action Inhibit viral replication Used to treat non- viral infections Influenza viruses HSV, VZV (another herpesvirus) CMV Hepatitis A, B, C (HAV, HBV, NCV) Mosby items and derived items 2005, 2002 by Mosby, Inc. 9 Mosby items and derived items 2005, 2002 by Mosby, Inc. 10 Antivirals: Synthetic Purine Nucleoside Analogues Purine nucleosides Guanine Adenosine Pyrimidine nucleosides Thymine Cytosine Uracil Mosby items and derived items 2005, 2002 by Mosby, Inc. 11 Antivirals: Purine Nucleosides Agent Antiviral Activity Guanines acyclovir HSV-1, HSV-2, VZV ganciclovir (DHPG) CMV retinitis and systemic CMV infection ribavirin (RTCD) Influenza types A and B, RSV, LV, HV Adenosines didanosine (ddl) vidarabine (Ara-A) HSV, herpes zoster Mosby items and derived items 2005, 2002 by Mosby, Inc. 12

Antivirals: Pyrimidine Nucleosides Agent Cytosines lamivudine (3TC) zalcitabine (ddc) Thymine idoxuridine (IDU) stavudine (d4t) trifluridine zidovudine (AZT) Antiviral Activity HSV HSV Mosby items and derived items 2005, 2002 by Mosby, Inc. 13 Mosby items and derived items 2005, 2002 by Mosby, Inc. 14 Other Antivirals: Nonretroviral amantadine (Symmetrel) and rimantadine (Flumadine) Influenza A foscarnet (Foscavir) CMV (retinitis and systemic) HSV infections Nonretrovirals: Neuraminidase Inhibitors oseltamivir (Tamiflu) and zanamivir (Relenza) Influenza types A and B acyclovir (Zovirax) HSV-1 and HSV-2, VZV (chickenpox or shingles) ganciclovir (Cytovene) CMV infections ribavirin (Copegus) Lower respiratory RSV infections in infants not indicated for adults Mosby items and derived items 2005, 2002 by Mosby, Inc. 15 Mosby items and derived items 2005, 2002 by Mosby, Inc. 16 Antivirals: Side Effects acyclovir Burning when topically applied, nausea, vomiting, diarrhea, headache amantadine and rimantadine Anticholinergic effects, insomnia, lightheadedness, anorexia, nausea, others didanosine Pancreatitis, peripheral neuropathies, seizures Antivirals: Side Effects (cont'd) zidovudine Bone marrow suppression, nausea, headache foscarnet Headache, seizures, acute renal failure, nausea, vomiting, diarrhea, others ganciclovir Bone marrow toxicity, nausea, anorexia, vomiting Mosby items and derived items 2005, 2002 by Mosby, Inc. 17 Mosby items and derived items 2005, 2002 by Mosby, Inc. 18

Figure 38-02 Human immunodeficiency virus (). Within the core capsid, the diploid, single-stranded, positive-sense RNA is complexed to nucleoprotein. (From Dorland s illustrated medical dictionary, ed 30, Philadelphia, 2003, WB Saunders.) Mosby items and derived items 2005, 2002 by Mosby, Inc. 19 Figure 38-03 Life cycle of the virus. The extracellular envelope protein gp120 binds to CD4 on the surface of T-lymphocytes or mononuclear phagocytes, while the transmembrane protein gp41 mediates the fusion of the viral envelope with the cell membrane. gp, Glycoprotein. (From Dorland s illustrated medical dictionary, ed 30, Philadelphia, 2003, WB Saunders.) Mosby items and derived items 2005, 2002 by Mosby, Inc. 20 Figure 38-04 Time course and stages of disease. A long clinical latency period follows the initial mononucleosis-like symptoms. The progressive decrease in the number of CD4 T-cells, even during the latency period, allows opportunistic infections to occur. The stages (World Health Organization and Centers for Disease Control and Prevention) in disease are defined by the CD4 T-cell levels and occurrence of opportunistic disease. ARC, Acquired immunodeficiency syndrome (AIDS)-related complex. (Redrawn from Redfield RR, Buske DS: infection: the clinical picture, Sci Am 259:90-98, 1988, updated 1996. In Murray PR et al: Medical microbiology, St. Louis, 2002, Mosby.) Human immunodeficiency virus infection ELISA (enzyme-linked immunosorbent assay) Detects exposure based on presence of human antibodies to the virus in the blood Retrovirus Transmitted by: Sexual activity, intravenous drug use, perinatally from mother to child Mosby items and derived items 2005, 2002 by Mosby, Inc. 21 Mosby items and derived items 2005, 2002 by Mosby, Inc. 22 Five Stages of Infection Stage 1: primary infection Stage 2: asymptomatic infection Stage 3: persistent generalized lymphadenopathy Stage 4: symptomatic stage Stage 5: progression to full-blown AIDS Opportunistic Infections Protozoal Toxoplasmosis of the brain, others Fungal Candiadiasis of the lungs, esophagus, trachea PCP, others Viral CMV disease, HSV infection, others Mosby items and derived items 2005, 2002 by Mosby, Inc. 23 Mosby items and derived items 2005, 2002 by Mosby, Inc. 24

Opportunistic Infections (cont'd) Bacterial Various mycobacterial infections, others Opportunistic neoplasias Kaposi s sarcoma, others Others wasting syndrome encephalopathy Lymphoid insterstitial pneumonia Antiretroviral Agents HAART Highly active antiretroviral therapy Includes at least three medications These medications work in different ways to reduce the viral load Mosby items and derived items 2005, 2002 by Mosby, Inc. 25 Mosby items and derived items 2005, 2002 by Mosby, Inc. 26 Reverse transcriptase inhibitors (RTIs) Block activity of the enzyme reverse transcriptase, preventing production of new viral DNA Protease inhibitors (PIs) Inhibit the protease retroviral enzyme, preventing viral replication Fusion inhibitors Inhibit viral fusion, preventing viral replication Reverse transcriptase inhibitors (RTIs) Nucleoside RTIs (NRTIs) Nonnucleoside RTIs (NNRTIs) Nucleotide RTIs (NTRTIs) Examples abacavir (Ziagen) delavirdine (Rescriptor) didanosine (Videx) lamivudine (Epivir) stavudine (Zerit) tenofovir (Viread) Mosby items and derived items 2005, 2002 by Mosby, Inc. 27 Mosby items and derived items 2005, 2002 by Mosby, Inc. 28 Protease inhibitors (PIs) Inhibit the protease retroviral enzyme, preventing viral replication Examples: amprenavir (Agenerase) indinavir (Crixivan) nelfinavir (Viracept) ritonavir (Norvir) saquinavir (Invirase) Fusion inhibitors Inhibit viral fusion, preventing viral replication Newest class of antiretroviral drugs Example: enfuvirtide (Fuzeon) Mosby items and derived items 2005, 2002 by Mosby, Inc. 29 Mosby items and derived items 2005, 2002 by Mosby, Inc. 30

Antiretroviral Agents: Side Effects Numerous and vary with each agent Drug therapy may need to be modified because of side effects Goal is to find the regimen that will best control the infection with a tolerable side effect profile Medication regimens change during the course of the illness Antivirals: Before beginning therapy, thoroughly assess underlying disease and medical history, including allergies Assess baseline VS and nutritional status Assess for contraindications, conditions that may indicate cautious use, and potential drug interactions Mosby items and derived items 2005, 2002 by Mosby, Inc. 31 Mosby items and derived items 2005, 2002 by Mosby, Inc. 32 Be sure to teach proper application technique for ointments, aerosol powders, etc. Emphasize handwashing before and after administration of medications to prevent site contamination and spread of infection Patients should wear a glove or finger cot when applying ointments or solutions to affected areas Instruct patients to consult their physician before taking any other medication, including OTCs Emphasize the importance of good hygiene Inform patients that antiviral agents are not cures but do help to manage symptoms Mosby items and derived items 2005, 2002 by Mosby, Inc. 33 Mosby items and derived items 2005, 2002 by Mosby, Inc. 34 Instruct patients on the importance of taking these medications exactly as prescribed and for the full course of treatment With zidovudine (AZT, ZDV, Retrovir): Inform patients that hair loss may occur so that they are prepared for this rare adverse reaction This medication should be taken on an empty stomach Monitor for side effects Effects are varied and specific to each agent Mosby items and derived items 2005, 2002 by Mosby, Inc. 35 Mosby items and derived items 2005, 2002 by Mosby, Inc. 36

Monitor for therapeutic effects Effects will vary depending on the type of viral infection Effects range from delayed progression of AIDS and ARC to decrease in flulike symptoms, decreased frequency of herpeslike flare-ups,or crusting over of herpetic lesions Mosby items and derived items 2005, 2002 by Mosby, Inc. 37